Also categorized in BoardMoves:
Intel CEO to retire as chipmaker struggles with mobile
x hide permanently

Albireo Elects Anne Klibanski and Stephanie Okey to Board of Directors


(GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the election of Anne Klibanski, M.D., and Stephanie Okey, M.S., to its board of directors...

Mentions: Stephanie Okey Albireo Pharma Anne Klibanski